logo
logo

Character Biosciences Strengthens Leadership Team With Appointment of Laura Carter, Ph.D. As Chief Scientific Officer Web Hosting

Sep 13, 2023almost 2 years ago

Position

Chief Scientific Officer

Company

Character Biosciences

Laura Carter
San Francisco

Description

SAN FRANCISCO––Character Biosciences, a drug discovery and development company leveraging human genetics and medical imaging-based machine learning to target disease progression, today announced the appointment of Laura Carter, Ph.D. as Chief Scientific Officer. Dr

Company Information

Company

Character Biosciences

Location

San Francisco, California, United States

About

Character Biosciences (formerly Clover Therapeutics) is a precision medicine platform that is unlocking the patterns of age-related diseases in people of diverse backgrounds. Our mission is to use human genetics to understand what drives diseases so we can discover targeted therapies to more effectively treat patients - many of whom lack any treatment options today. Character partners with patients, providers, payers, and scientists to create deeply-phenotyped patient cohorts to enable clinical genomic research. Our approach integrates genomics, longitudinal clinical and imaging data, machine learning, and novel experimental approaches to identify the molecular drivers of disease progression and develop innovative targeted medicines.

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Related People

Laura hidden

hidden
hidden